Clinical trial

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

NCT03317028

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-10

PhasePHASE2

Study timeline

Study start (actual)2017-10-10Date precision: day

Registry last updated2020-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

T2DM With Inadequate Glycemic Controlunresolved

Interventions

CS02 tablet and placebo tabletDRUG

Sponsors & collaborators

Center Laboratories, Inc.lead sponsor

Mapped research locations

TaipeiTaiwan3 TaichungTaiwan3 Kaohsiung CityTaiwan2 Little RockArkansas, United States1 TainanTaiwan1 HialeahFlorida, United States1 TaoyuanTaiwan1 Coral GablesFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03317028 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.